{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:48Z","timestamp":1793831268357,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatectomy with associated vascular resection and reconstruction (VR) is an option to increase the number of patients with locally advanced perihilar cholangiocarcinoma (pCCA) eligible for radical-intent surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to assess the safety and oncological outcomes of VR in pCCA patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients who underwent surgery for pCCA at 10 western centers were retrospectively reviewed and divided according to the performance of the VR. Primary outcomes were major morbidity, vascular morbidity, 90-day mortality, and overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1054 patients were included, of whom 259 (24.6%) underwent VR. Of these 259 patients, 199 (76.8 %) underwent portal vein reconstruction (PVR) only and 60 (23.2%) underwent hepatic artery reconstruction (HAR) with or without PVR. VR patients were younger (66 vs. 68\u00a0years;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.011) and more frequently had Bismuth type 4 tumors (31.3% vs. 22.9%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.008). They more frequently underwent portal vein embolization (32.0% vs. 17.6%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001), biliary drainage (84.9% vs. 77.3%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.008), and extended hepatectomy (56.8% vs. 37.1%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001), with longer operative times (539 vs. 479\u00a0min;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001) and higher blood loss (1300 vs. 700\u00a0mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001). Positive resection margins were observed more frequently (45.7% vs. 35.2%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.003). Major complications (51.4% vs. 41.0%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.004), vascular complications (19.7% vs. 3.3%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001), and mortality (16.2% vs. 10.6%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.02) were higher in VR patients. Median OS was 28.0 months for patients without VR versus 22.8 months for patients with VR (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.18).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Liver resection and VR in patients with locally advanced pCCA are associated with increased major and vascular morbidity but offer similar survival as patients not undergoing VR; therefore, VR should be considered in selected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-18137-4","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T17:32:37Z","timestamp":1757784757000},"page":"9597-9607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar Cholangiocarcinoma"],"prefix":"10.1245","volume":"32","author":[{"given":"Edoardo","family":"Poletto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim B.","family":"Olthof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik J. H.","family":"Hoogwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris I.","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas A.","family":"Schnitzbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Sparrelid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Dopazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul R.","family":"Hakeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ruzzenente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Groot Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Perihilar Cholangiocarcinoma Collaboration Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. O.","family":"Bechstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Charco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. C.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gomez-Gavara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"van Gulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. N. M.","family":"IJzermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kazemier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. A.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"key":"18137_CR1","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/SLA.0000000000005103","volume":"274","author":"M Mueller","year":"2021","unstructured":"Mueller M, Breuer E, Mizuno T, et al. Perihilar cholangiocarcinoma\u2014novel benchmark values for surgical and oncological outcomes from 24 expert centers. Ann Surg. 2021;274:780\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000005103.","journal-title":"Ann Surg"},{"key":"18137_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","volume":"258","author":"M Nagino","year":"2013","unstructured":"Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129\u201340. https:\/\/doi.org\/10.1097\/SLA.0b013e3182708b57.","journal-title":"Ann Surg"},{"key":"18137_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol. 2016;13:261\u201380. https:\/\/doi.org\/10.1038\/nrgastro.2016.51.","journal-title":"Nat Rev Gastroenterol"},{"key":"18137_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153657","author":"A Lauterio","year":"2021","unstructured":"Lauterio A, De Carlis R, Centonze L, et al. Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13153657.","journal-title":"Cancers"},{"key":"18137_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1111\/liv.14856","volume":"41","author":"A-M van Keulen","year":"2021","unstructured":"van Keulen A-M, Franssen S, van der Geest LG, et al. Nationwide treatment and outcomes of perihilar cholangiocarcinoma. Liver Int. 2021;41:1945\u201353. https:\/\/doi.org\/10.1111\/liv.14856.","journal-title":"Liver Int"},{"key":"18137_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092208","author":"DB Hewitt","year":"2022","unstructured":"Hewitt DB, Brown ZJ, Pawlik TM. Current perspectives on the surgical management of perihilar cholangiocarcinoma. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14092208.","journal-title":"Cancers"},{"key":"18137_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215278","author":"A Serrablo","year":"2021","unstructured":"Serrablo A, Serrablo L, Alikhanov R, Tejedor L. Vascular resection in perihilar cholangiocarcinoma. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13215278.","journal-title":"Cancers"},{"key":"18137_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/SLA.0000000000004322","volume":"275","author":"T Mizuno","year":"2022","unstructured":"Mizuno T, Ebata T, Yokoyama Y, et al. Combined vascular resection for locally advanced perihilar cholangiocarcinoma. Ann Surg. 2022;275:382\u201390. https:\/\/doi.org\/10.1097\/SLA.0000000000004322.","journal-title":"Ann Surg"},{"key":"18137_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.surg.2006.09.016","volume":"141","author":"M Miyazaki","year":"2007","unstructured":"Miyazaki M, Kato A, Ito H, et al. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery. 2007;141:581\u20138. https:\/\/doi.org\/10.1016\/j.surg.2006.09.016.","journal-title":"Surgery"},{"key":"18137_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1477-2574.2012.00616.x","volume":"15","author":"S Abbas","year":"2013","unstructured":"Abbas S, Sandroussi C. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB. 2013;15:492\u2013503. https:\/\/doi.org\/10.1111\/j.1477-2574.2012.00616.x.","journal-title":"HPB"},{"key":"18137_CR11","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1007\/s11605-021-05004-2","volume":"25","author":"N Kuriyama","year":"2021","unstructured":"Kuriyama N, Komatsubara H, Nakagawa Y, et al. Impact of combined vascular resection and reconstruction in patients with advanced perihilar cholangiocarcinoma. J Gastrointest Surg. 2021;25:3108\u201318. https:\/\/doi.org\/10.1007\/s11605-021-05004-2.","journal-title":"J Gastrointest Surg"},{"key":"18137_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.hpb.2017.08.025","volume":"20","author":"JLA van Vugt","year":"2018","unstructured":"van Vugt JLA, Gaspersz MP, Coelen RJS, et al. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB. 2018;20:83\u201392. https:\/\/doi.org\/10.1016\/j.hpb.2017.08.025.","journal-title":"HPB"},{"key":"18137_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12957-022-02692-1","volume":"20","author":"Y Song","year":"2022","unstructured":"Song Y, Zhang Y, Zhen Z, Huang Z. Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis. World J Surg Oncol. 2022;20:230. https:\/\/doi.org\/10.1186\/s12957-022-02692-1.","journal-title":"World J Surg Oncol"},{"key":"18137_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00534-005-0999-7","volume":"12","author":"SM Strasberg","year":"2005","unstructured":"Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12:351\u20135. https:\/\/doi.org\/10.1007\/s00534-005-0999-7.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"18137_CR15","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s11605-019-04127-x","volume":"24","author":"MP Gaspersz","year":"2020","unstructured":"Gaspersz MP, Buettner S, van Vugt JLA, et al. Evaluation of the New American Joint Committee on cancer staging manual 8th edition for perihilar cholangiocarcinoma. J Gastrointest Surg. 2020;24:1612\u20138. https:\/\/doi.org\/10.1007\/s11605-019-04127-x.","journal-title":"J Gastrointest Surg"},{"key":"18137_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg"},{"key":"18137_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","volume":"149","author":"NN Rahbari","year":"2011","unstructured":"Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713\u201324. https:\/\/doi.org\/10.1016\/j.surg.2010.10.001.","journal-title":"Surgery"},{"key":"18137_CR18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1477-2574.2011.00319.x","volume":"13","author":"NN Rahbari","year":"2011","unstructured":"Rahbari NN, Garden OJ, Padbury R, et al. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB. 2011;13:528\u201335. https:\/\/doi.org\/10.1111\/j.1477-2574.2011.00319.x.","journal-title":"HPB"},{"key":"18137_CR19","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.surg.2010.12.002","volume":"149","author":"M Koch","year":"2011","unstructured":"Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149:680\u20138. https:\/\/doi.org\/10.1016\/j.surg.2010.12.002.","journal-title":"Surgery"},{"key":"18137_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.hpb.2018.07.014","volume":"21","author":"PB Olthof","year":"2019","unstructured":"Olthof PB, Miyasaka M, Koerkamp BG, et al. A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers. HPB. 2019;21:345\u201351. https:\/\/doi.org\/10.1016\/j.hpb.2018.07.014.","journal-title":"HPB"},{"key":"18137_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jviscsurg.2023.06.005","volume":"160","author":"M Lemaire","year":"2023","unstructured":"Lemaire M, Vibert \u00c9, Azoulay D, et al. Early portal vein thrombosis after hepatectomy for perihilar cholangiocarcinoma: Incidence, risk factors, and management. J Visc Surg. 2023;160:417\u201326. https:\/\/doi.org\/10.1016\/j.jviscsurg.2023.06.005.","journal-title":"J Visc Surg"},{"key":"18137_CR22","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1245\/s10434-020-08239-6","volume":"27","author":"JY Liu","year":"2020","unstructured":"Liu JY, Ellis RJ, Hu QL, et al. Post Hepatectomy liver failure risk calculator for preoperative and early postoperative period following major hepatectomy. Ann Surg Oncol. 2020;27:2868\u201376. https:\/\/doi.org\/10.1245\/s10434-020-08239-6.","journal-title":"Ann Surg Oncol"},{"key":"18137_CR23","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1007\/s00268-022-06742-3","volume":"46","author":"G Orozco","year":"2022","unstructured":"Orozco G, Gupta M, Villagomez D, et al. Predictors of liver failure in non-cirrhotic patients undergoing hepatectomy. World J Surg. 2022;46:3081\u20139. https:\/\/doi.org\/10.1007\/s00268-022-06742-3.","journal-title":"World J Surg"},{"key":"18137_CR24","doi-asserted-by":"publisher","first-page":"e12025","DOI":"10.1097\/MD.0000000000012025","volume":"97","author":"Y Wang","year":"2018","unstructured":"Wang Y, Fu W, Tang Z, et al. Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97:e12025. https:\/\/doi.org\/10.1097\/MD.0000000000012025.","journal-title":"Medicine (Baltimore)."},{"key":"18137_CR25","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1007\/s11605-018-3861-3","volume":"22","author":"R Ramanathan","year":"2018","unstructured":"Ramanathan R, Borrebach J, Tohme S, Tsung A. Preoperative biliary drainage is associated with increased complications after liver resection for proximal cholangiocarcinoma. J Gastrointest Surg. 2018;22:1950\u20137. https:\/\/doi.org\/10.1007\/s11605-018-3861-3.","journal-title":"J Gastrointest Surg"},{"key":"18137_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12957-020-01904-w","volume":"18","author":"F Teng","year":"2020","unstructured":"Teng F, Tang Y-Y, Dai J-L, et al. The effect and safety of preoperative biliary drainage in patients with hilar cholangiocarcinoma: an updated meta-analysis. World J Surg Oncol. 2020;18:174. https:\/\/doi.org\/10.1186\/s12957-020-01904-w.","journal-title":"World J Surg Oncol"},{"key":"18137_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.surg.2022.04.028","volume":"172","author":"A Ruzzenente","year":"2022","unstructured":"Ruzzenente A, Alaimo L, Caputo M, et al. Infectious complications after surgery for perihilar cholangiocarcinoma: a single Western center experience. Surgery. 2022;172:813\u201320. https:\/\/doi.org\/10.1016\/j.surg.2022.04.028.","journal-title":"Surgery"},{"key":"18137_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jamcollsurg.2016.01.060","volume":"223","author":"D Ribero","year":"2016","unstructured":"Ribero D, Zimmitti G, Aloia TA, et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg. 2016;223:87\u201397. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2016.01.060.","journal-title":"J Am Coll Surg"},{"key":"18137_CR29","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1245\/s10434-024-15115-0","volume":"31","author":"PB Olthof","year":"2024","unstructured":"Olthof PB, Erdmann JI, Alikhanov R, et al. Higher postoperative mortality and inferior survival after right-sided liver resection for perihilar cholangiocarcinoma: left-sided resection is preferred when possible. Ann Surg Oncol. 2024;31:4405\u201312. https:\/\/doi.org\/10.1245\/s10434-024-15115-0.","journal-title":"Ann Surg Oncol"},{"key":"18137_CR30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.hpb.2017.10.003","volume":"20","author":"GV Schimizzi","year":"2018","unstructured":"Schimizzi GV, Jin LX, Davidson JT 4th, et al. Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium. HPB. 2018;20:332\u20139. https:\/\/doi.org\/10.1016\/j.hpb.2017.10.003.","journal-title":"HPB"},{"key":"18137_CR31","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s11605-018-3711-3","volume":"22","author":"H-J Hu","year":"2018","unstructured":"Hu H-J, Jin Y-W, Zhou R-X, et al. Hepatic artery resection for bismuth type III and IV hilar cholangiocarcinoma: is reconstruction always required? J Gastrointest Surg. 2018;22:1204\u201312. https:\/\/doi.org\/10.1007\/s11605-018-3711-3.","journal-title":"J Gastrointest Surg"},{"key":"18137_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1245\/s10434-016-5381-2","volume":"23","author":"R Matsuyama","year":"2016","unstructured":"Matsuyama R, Mori R, Ota Y, et al. Significance of vascular resection and reconstruction in surgery for hilar cholangiocarcinoma: with special reference to hepatic arterial resection and reconstruction. Ann Surg Oncol. 2016;23:475\u201384. https:\/\/doi.org\/10.1245\/s10434-016-5381-2.","journal-title":"Ann Surg Oncol"},{"key":"18137_CR33","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/ans.15969","volume":"90","author":"WH She","year":"2020","unstructured":"She WH, Cheung TT, Ma KW, et al. Vascular resection and reconstruction in hilar cholangiocarcinoma. ANZ J Surg. 2020;90:1653\u20139. https:\/\/doi.org\/10.1111\/ans.15969.","journal-title":"ANZ J Surg"},{"key":"18137_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.21037\/hbsn.2019.07.19","volume":"8","author":"RF de Wilde","year":"2019","unstructured":"de Wilde RF, Koerkamp BG. Radial margin status should be determined in resected perihilar cholangiocarcinoma. Hepatobiliary Surg Nutr. 2019;8:557\u20139. https:\/\/doi.org\/10.21037\/hbsn.2019.07.19.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"18137_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246126","author":"M De Bellis","year":"2022","unstructured":"De Bellis M, Mastrosimini MG, Conci S, et al. The prognostic role of true radical resection in perihilar cholangiocarcinoma after improved evaluation of radial margin status. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14246126.","journal-title":"Cancers"},{"key":"18137_CR36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00428-019-02621-w","volume":"475","author":"E Roos","year":"2019","unstructured":"Roos E, Franken LC, Soer EC, et al. Lost in translation: confusion on resection and dissection planes hampers the interpretation of pathology reports for perihilar cholangiocarcinoma. Virchows Arch Int J Pathol. 2019;475:435\u201343. https:\/\/doi.org\/10.1007\/s00428-019-02621-w.","journal-title":"Virchows Arch Int J Pathol"},{"key":"18137_CR37","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00268-012-1638-5","volume":"36","author":"AT Ruys","year":"2012","unstructured":"Ruys AT, van Haelst S, Busch OR, et al. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg. 2012;36:2179\u201386. https:\/\/doi.org\/10.1007\/s00268-012-1638-5.","journal-title":"World J Surg"},{"key":"18137_CR38","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","volume":"9","author":"D-Y Oh","year":"2024","unstructured":"Oh D-Y, He AR, Bouattour M, et al. Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study. Lancet Gastroenterol Hepatol. 2024;9:694\u2013704. https:\/\/doi.org\/10.1016\/S2468-1253(24)00095-5.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"18137_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/SLA.0000000000005641","volume":"276","author":"E Breuer","year":"2022","unstructured":"Breuer E, Mueller M, Doyle MB, et al. Liver transplantation as a new standard of care in patients with perihilar cholangiocarcinoma? results from an international benchmark study. Ann Surg. 2022;276:846\u201353.","journal-title":"Ann Surg"},{"key":"18137_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","volume":"242","author":"DJ Rea","year":"2005","unstructured":"Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451\u20138. https:\/\/doi.org\/10.1097\/01.sla.0000179678.13285.fa. (discussion 458-461).","journal-title":"Ann Surg"},{"key":"18137_CR41","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1245\/s10434-020-09001-8","volume":"28","author":"JJA Vugts","year":"2021","unstructured":"Vugts JJA, Gaspersz MP, Roos E, et al. Eligibility for liver transplantation in patients with perihilar cholangiocarcinoma. Ann Surg Oncol. 2021;28:1483\u201392. https:\/\/doi.org\/10.1245\/s10434-020-09001-8.","journal-title":"Ann Surg Oncol"},{"key":"18137_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jamcollsurg.2015.01.064","volume":"221","author":"KP Croome","year":"2015","unstructured":"Croome KP, Rosen CB, Heimbach JK, Nagorney DM. Is liver transplantation appropriate for patients with potentially resectable de novo hilar cholangiocarcinoma? J Am Coll Surg. 2015;221:130\u20139. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.01.064.","journal-title":"J Am Coll Surg"},{"key":"18137_CR43","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/lt.21107","volume":"13","author":"HTJ Mantel","year":"2007","unstructured":"Mantel HTJ, Rosen CB, Heimbach JK, et al. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transplant. 2007;13:1372\u201381. https:\/\/doi.org\/10.1002\/lt.21107.","journal-title":"Liver Transplant"},{"key":"18137_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/bjs.10776","volume":"105","author":"T Ebata","year":"2018","unstructured":"Ebata T, Hirano S, Konishi M, et al. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer. Br J. 2018;105:192\u2013202. https:\/\/doi.org\/10.1002\/bjs.10776.","journal-title":"Br J"},{"key":"18137_CR45","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1200\/JCO.21.02568","volume":"40","author":"J Bridgewater","year":"2022","unstructured":"Bridgewater J, Fletcher P, Palmer DH, et al. Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study. J Clin Oncol. 2022;40:2048\u201357. https:\/\/doi.org\/10.1200\/JCO.21.02568.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18137-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:17:59Z","timestamp":1762352279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18137-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":45,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["18137"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18137-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,13]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Edoardo Poletto, Pim B. Olthof, Frederik J.H. Hoogwater, Joris I. Erdmann, Andreas A. Schnitzbauer, Ernesto Sparrelid, Shishir K. Maithel, Cristina Dopazo, Abdul R. Hakeem, Francesca Ratti, Andrea Ruzzenente, and Bas Groot Koerkamp have no conflicts of interest or financial ties to declare that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The present study was approved by the Erasmus MC Ethical Committee and consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}